Loading…

Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study

Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence o...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2023-12, Vol.24 (24), p.17292
Main Authors: Niemiec, Paweł, Jarosz, Alicja, Balcerzyk-Matić, Anna, Iwanicka, Joanna, Nowak, Tomasz, Iwanicki, Tomasz, Gierek, Marcin, Kalita, Marcin, Garczorz, Wojciech, Francuz, Tomasz, Górczyńska-Kosiorz, Sylwia, Kania, Wojciech, Szyluk, Karol
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3
cites cdi_FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3
container_end_page
container_issue 24
container_start_page 17292
container_title International journal of molecular sciences
container_volume 24
creator Niemiec, Paweł
Jarosz, Alicja
Balcerzyk-Matić, Anna
Iwanicka, Joanna
Nowak, Tomasz
Iwanicki, Tomasz
Gierek, Marcin
Kalita, Marcin
Garczorz, Wojciech
Francuz, Tomasz
Górczyńska-Kosiorz, Sylwia
Kania, Wojciech
Szyluk, Karol
description Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence of gene variants on the effectiveness of tennis elbow therapy using platelet-rich plasma (PRP), measured through common patient-reported outcome measures (PROMs). A cohort of 107 patients (132 elbows) with tennis elbow was prospectively analyzed, with a two-year follow-up (at weeks 2, 4, 8, 12, 24, 52, and 104 after PRP injection). PROMs values were compared between variants of five gene polymorphisms (rs699947 A>C, rs2010963 C>G, rs1413711 C>T, rs3024998 C>T and rs3025021 C>T) at each follow-up point. Patients with genotypes GG (rs2010963) and CC (rs3024998) had better response to PRP therapy (significantly fewer symptoms and limitations in the upper limb compared to carriers of alleles C and T, respectively). Polymorphisms influenced also selected hematological parameters. gene polymorphisms (rs2010963 and rs3024998) appear to be significant treatment modifiers for tendinopathy, and their genotyping may serve as an effective tool for personalized patient selection for PRP therapy.
doi_str_mv 10.3390/ijms242417292
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8235a0a81f474734a9b8f3c598bfde12</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8235a0a81f474734a9b8f3c598bfde12</doaj_id><sourcerecordid>2904659043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3</originalsourceid><addsrcrecordid>eNpdkc1vEzEQxS0Eom3gyBVZ4sJlwV-73uUWRWmIVIkIQiVOlu0dE0ebdbB3iXLvH45DSkV78Vie3zyN30PoDSUfOG_IR7_dJSaYoJI17Bm6pIKxgpBKPv_vfoGuUtoSwjgrm5fogteUN5TxS3S3gB4Gb_Gtjl4b3_nhiH2Pb-eL6yk-NfGyd90IvYWEhw3guXNgB_87t1LCweE19L1PeN6ZcMDrDUS9P-KDHzZ49XX1CU_x-hCKH6AjXsWQ9udhPAubEAf8bRjb4yv0wukuwev7OkHfr-fr2efi5stiOZveFFawaig4YUbK0rESqLCUSmtK01owknLRCAY1cCZdbSstK2YlNbwyRHJaV1KYVvMJWp5126C3ah_9TsejCtqrvw8h_lQ6ZjM6UDXjpSa6pk5IIbnQjakdt2VTG9dCtm6C3p-19jH8GiENaueTha7TPYQxKdaQsmQ5FZnRd0_QbRhjn396okRV5oNnqjhTNruUIriHBSlRp6jVo6gz__ZedTQ7aB_of9nyPz4qoqs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2904659043</pqid></control><display><type>article</type><title>Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study</title><source>PubMed (Medline)</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Niemiec, Paweł ; Jarosz, Alicja ; Balcerzyk-Matić, Anna ; Iwanicka, Joanna ; Nowak, Tomasz ; Iwanicki, Tomasz ; Gierek, Marcin ; Kalita, Marcin ; Garczorz, Wojciech ; Francuz, Tomasz ; Górczyńska-Kosiorz, Sylwia ; Kania, Wojciech ; Szyluk, Karol</creator><creatorcontrib>Niemiec, Paweł ; Jarosz, Alicja ; Balcerzyk-Matić, Anna ; Iwanicka, Joanna ; Nowak, Tomasz ; Iwanicki, Tomasz ; Gierek, Marcin ; Kalita, Marcin ; Garczorz, Wojciech ; Francuz, Tomasz ; Górczyńska-Kosiorz, Sylwia ; Kania, Wojciech ; Szyluk, Karol</creatorcontrib><description>Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence of gene variants on the effectiveness of tennis elbow therapy using platelet-rich plasma (PRP), measured through common patient-reported outcome measures (PROMs). A cohort of 107 patients (132 elbows) with tennis elbow was prospectively analyzed, with a two-year follow-up (at weeks 2, 4, 8, 12, 24, 52, and 104 after PRP injection). PROMs values were compared between variants of five gene polymorphisms (rs699947 A&gt;C, rs2010963 C&gt;G, rs1413711 C&gt;T, rs3024998 C&gt;T and rs3025021 C&gt;T) at each follow-up point. Patients with genotypes GG (rs2010963) and CC (rs3024998) had better response to PRP therapy (significantly fewer symptoms and limitations in the upper limb compared to carriers of alleles C and T, respectively). Polymorphisms influenced also selected hematological parameters. gene polymorphisms (rs2010963 and rs3024998) appear to be significant treatment modifiers for tendinopathy, and their genotyping may serve as an effective tool for personalized patient selection for PRP therapy.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms242417292</identifier><identifier>PMID: 38139123</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Angiogenesis ; Blood platelets ; Collagen ; Elbow ; Extracellular matrix ; Genes ; genetic polymorphism ; Genotype &amp; phenotype ; Haplotypes ; Influence ; Patients ; Physiology ; platelet-rich plasma ; Polymorphism ; tendinopathy ; Tendons ; tennis elbow ; Vascular endothelial growth factor ; VEGFA</subject><ispartof>International journal of molecular sciences, 2023-12, Vol.24 (24), p.17292</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3</citedby><cites>FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3</cites><orcidid>0000-0002-6321-6090 ; 0000-0002-8686-9692 ; 0000-0003-0044-3162 ; 0000-0002-8159-6437 ; 0000-0002-3609-9554 ; 0000-0002-1113-7796 ; 0000-0001-6669-7216 ; 0000-0002-0853-9014 ; 0000-0002-5343-1205</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2904659043/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2904659043?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38139123$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niemiec, Paweł</creatorcontrib><creatorcontrib>Jarosz, Alicja</creatorcontrib><creatorcontrib>Balcerzyk-Matić, Anna</creatorcontrib><creatorcontrib>Iwanicka, Joanna</creatorcontrib><creatorcontrib>Nowak, Tomasz</creatorcontrib><creatorcontrib>Iwanicki, Tomasz</creatorcontrib><creatorcontrib>Gierek, Marcin</creatorcontrib><creatorcontrib>Kalita, Marcin</creatorcontrib><creatorcontrib>Garczorz, Wojciech</creatorcontrib><creatorcontrib>Francuz, Tomasz</creatorcontrib><creatorcontrib>Górczyńska-Kosiorz, Sylwia</creatorcontrib><creatorcontrib>Kania, Wojciech</creatorcontrib><creatorcontrib>Szyluk, Karol</creatorcontrib><title>Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence of gene variants on the effectiveness of tennis elbow therapy using platelet-rich plasma (PRP), measured through common patient-reported outcome measures (PROMs). A cohort of 107 patients (132 elbows) with tennis elbow was prospectively analyzed, with a two-year follow-up (at weeks 2, 4, 8, 12, 24, 52, and 104 after PRP injection). PROMs values were compared between variants of five gene polymorphisms (rs699947 A&gt;C, rs2010963 C&gt;G, rs1413711 C&gt;T, rs3024998 C&gt;T and rs3025021 C&gt;T) at each follow-up point. Patients with genotypes GG (rs2010963) and CC (rs3024998) had better response to PRP therapy (significantly fewer symptoms and limitations in the upper limb compared to carriers of alleles C and T, respectively). Polymorphisms influenced also selected hematological parameters. gene polymorphisms (rs2010963 and rs3024998) appear to be significant treatment modifiers for tendinopathy, and their genotyping may serve as an effective tool for personalized patient selection for PRP therapy.</description><subject>Angiogenesis</subject><subject>Blood platelets</subject><subject>Collagen</subject><subject>Elbow</subject><subject>Extracellular matrix</subject><subject>Genes</subject><subject>genetic polymorphism</subject><subject>Genotype &amp; phenotype</subject><subject>Haplotypes</subject><subject>Influence</subject><subject>Patients</subject><subject>Physiology</subject><subject>platelet-rich plasma</subject><subject>Polymorphism</subject><subject>tendinopathy</subject><subject>Tendons</subject><subject>tennis elbow</subject><subject>Vascular endothelial growth factor</subject><subject>VEGFA</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkc1vEzEQxS0Eom3gyBVZ4sJlwV-73uUWRWmIVIkIQiVOlu0dE0ebdbB3iXLvH45DSkV78Vie3zyN30PoDSUfOG_IR7_dJSaYoJI17Bm6pIKxgpBKPv_vfoGuUtoSwjgrm5fogteUN5TxS3S3gB4Gb_Gtjl4b3_nhiH2Pb-eL6yk-NfGyd90IvYWEhw3guXNgB_87t1LCweE19L1PeN6ZcMDrDUS9P-KDHzZ49XX1CU_x-hCKH6AjXsWQ9udhPAubEAf8bRjb4yv0wukuwev7OkHfr-fr2efi5stiOZveFFawaig4YUbK0rESqLCUSmtK01owknLRCAY1cCZdbSstK2YlNbwyRHJaV1KYVvMJWp5126C3ah_9TsejCtqrvw8h_lQ6ZjM6UDXjpSa6pk5IIbnQjakdt2VTG9dCtm6C3p-19jH8GiENaueTha7TPYQxKdaQsmQ5FZnRd0_QbRhjn396okRV5oNnqjhTNruUIriHBSlRp6jVo6gz__ZedTQ7aB_of9nyPz4qoqs</recordid><startdate>20231209</startdate><enddate>20231209</enddate><creator>Niemiec, Paweł</creator><creator>Jarosz, Alicja</creator><creator>Balcerzyk-Matić, Anna</creator><creator>Iwanicka, Joanna</creator><creator>Nowak, Tomasz</creator><creator>Iwanicki, Tomasz</creator><creator>Gierek, Marcin</creator><creator>Kalita, Marcin</creator><creator>Garczorz, Wojciech</creator><creator>Francuz, Tomasz</creator><creator>Górczyńska-Kosiorz, Sylwia</creator><creator>Kania, Wojciech</creator><creator>Szyluk, Karol</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6321-6090</orcidid><orcidid>https://orcid.org/0000-0002-8686-9692</orcidid><orcidid>https://orcid.org/0000-0003-0044-3162</orcidid><orcidid>https://orcid.org/0000-0002-8159-6437</orcidid><orcidid>https://orcid.org/0000-0002-3609-9554</orcidid><orcidid>https://orcid.org/0000-0002-1113-7796</orcidid><orcidid>https://orcid.org/0000-0001-6669-7216</orcidid><orcidid>https://orcid.org/0000-0002-0853-9014</orcidid><orcidid>https://orcid.org/0000-0002-5343-1205</orcidid></search><sort><creationdate>20231209</creationdate><title>Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study</title><author>Niemiec, Paweł ; Jarosz, Alicja ; Balcerzyk-Matić, Anna ; Iwanicka, Joanna ; Nowak, Tomasz ; Iwanicki, Tomasz ; Gierek, Marcin ; Kalita, Marcin ; Garczorz, Wojciech ; Francuz, Tomasz ; Górczyńska-Kosiorz, Sylwia ; Kania, Wojciech ; Szyluk, Karol</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Angiogenesis</topic><topic>Blood platelets</topic><topic>Collagen</topic><topic>Elbow</topic><topic>Extracellular matrix</topic><topic>Genes</topic><topic>genetic polymorphism</topic><topic>Genotype &amp; phenotype</topic><topic>Haplotypes</topic><topic>Influence</topic><topic>Patients</topic><topic>Physiology</topic><topic>platelet-rich plasma</topic><topic>Polymorphism</topic><topic>tendinopathy</topic><topic>Tendons</topic><topic>tennis elbow</topic><topic>Vascular endothelial growth factor</topic><topic>VEGFA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niemiec, Paweł</creatorcontrib><creatorcontrib>Jarosz, Alicja</creatorcontrib><creatorcontrib>Balcerzyk-Matić, Anna</creatorcontrib><creatorcontrib>Iwanicka, Joanna</creatorcontrib><creatorcontrib>Nowak, Tomasz</creatorcontrib><creatorcontrib>Iwanicki, Tomasz</creatorcontrib><creatorcontrib>Gierek, Marcin</creatorcontrib><creatorcontrib>Kalita, Marcin</creatorcontrib><creatorcontrib>Garczorz, Wojciech</creatorcontrib><creatorcontrib>Francuz, Tomasz</creatorcontrib><creatorcontrib>Górczyńska-Kosiorz, Sylwia</creatorcontrib><creatorcontrib>Kania, Wojciech</creatorcontrib><creatorcontrib>Szyluk, Karol</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niemiec, Paweł</au><au>Jarosz, Alicja</au><au>Balcerzyk-Matić, Anna</au><au>Iwanicka, Joanna</au><au>Nowak, Tomasz</au><au>Iwanicki, Tomasz</au><au>Gierek, Marcin</au><au>Kalita, Marcin</au><au>Garczorz, Wojciech</au><au>Francuz, Tomasz</au><au>Górczyńska-Kosiorz, Sylwia</au><au>Kania, Wojciech</au><au>Szyluk, Karol</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2023-12-09</date><risdate>2023</risdate><volume>24</volume><issue>24</issue><spage>17292</spage><pages>17292-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Vascular endothelial growth factor (VEGF) is implicated in both the etiology of tendinopathy and its healing process. Polymorphic variants of the gene exhibit varied expression, which can influence the phenotype and treatment effectiveness. The aim of the present study was to analyze the influence of gene variants on the effectiveness of tennis elbow therapy using platelet-rich plasma (PRP), measured through common patient-reported outcome measures (PROMs). A cohort of 107 patients (132 elbows) with tennis elbow was prospectively analyzed, with a two-year follow-up (at weeks 2, 4, 8, 12, 24, 52, and 104 after PRP injection). PROMs values were compared between variants of five gene polymorphisms (rs699947 A&gt;C, rs2010963 C&gt;G, rs1413711 C&gt;T, rs3024998 C&gt;T and rs3025021 C&gt;T) at each follow-up point. Patients with genotypes GG (rs2010963) and CC (rs3024998) had better response to PRP therapy (significantly fewer symptoms and limitations in the upper limb compared to carriers of alleles C and T, respectively). Polymorphisms influenced also selected hematological parameters. gene polymorphisms (rs2010963 and rs3024998) appear to be significant treatment modifiers for tendinopathy, and their genotyping may serve as an effective tool for personalized patient selection for PRP therapy.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38139123</pmid><doi>10.3390/ijms242417292</doi><orcidid>https://orcid.org/0000-0002-6321-6090</orcidid><orcidid>https://orcid.org/0000-0002-8686-9692</orcidid><orcidid>https://orcid.org/0000-0003-0044-3162</orcidid><orcidid>https://orcid.org/0000-0002-8159-6437</orcidid><orcidid>https://orcid.org/0000-0002-3609-9554</orcidid><orcidid>https://orcid.org/0000-0002-1113-7796</orcidid><orcidid>https://orcid.org/0000-0001-6669-7216</orcidid><orcidid>https://orcid.org/0000-0002-0853-9014</orcidid><orcidid>https://orcid.org/0000-0002-5343-1205</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2023-12, Vol.24 (24), p.17292
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_8235a0a81f474734a9b8f3c598bfde12
source PubMed (Medline); Publicly Available Content Database (Proquest) (PQ_SDU_P3)
subjects Angiogenesis
Blood platelets
Collagen
Elbow
Extracellular matrix
Genes
genetic polymorphism
Genotype & phenotype
Haplotypes
Influence
Patients
Physiology
platelet-rich plasma
Polymorphism
tendinopathy
Tendons
tennis elbow
Vascular endothelial growth factor
VEGFA
title Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A25%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20Variability%20in%20VEGFA%20Gene%20Influences%20the%20Effectiveness%20of%20Tennis%20Elbow%20Therapy%20with%20PRP:%20A%20Two-Year%20Prospective%20Cohort%20Study&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Niemiec,%20Pawe%C5%82&rft.date=2023-12-09&rft.volume=24&rft.issue=24&rft.spage=17292&rft.pages=17292-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms242417292&rft_dat=%3Cproquest_doaj_%3E2904659043%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c426t-302b775f25e14c117cb5bdceb7134942e8e327f8c6a762c71b36b07318674bda3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2904659043&rft_id=info:pmid/38139123&rfr_iscdi=true